1 financial community briefing september 2006 2 nicox participants to the invited guest thomas schnitzer professor and assistant dean for clinical research northwestern university feinberg school of medicine chicago senior management team michele garufi chief executive officer maarten beekman vp development eric castaldi damian marron corporate ennio ongini staffan stromberg drug investor relations karl hanks com 33 497152203 3 agenda introduction m product generation e naproxcinod hct 3012 need safer nsaids tj market overview positioning d phase plan s ncx 4016 re directing novel insulin sensitizer treat type diabetes no donating statins 6560 a new nitric oxide statin derivative status ongoing alliances review moving from an r&d company fully integrated pharma 4 transformation headcount increasing in line with activities our advanced programmes partnerships internal finance future growth 0 10 20 30 40 50 60 70 80 90
